Q2 FY2026 EarningsQ2 FY26 net loss of $3.35M beat consensus expectations of a $3.60M loss, while GAAP EPS of -$0.17 beat the -$0.23 consensus. Revenue remained at zero in-line with expectations as the company continues its pre-commercial clinical phase. Cash reserves increased to $6.7M following a $10.4M private placement, helping the company regain compliance with NYSE American equity requirements ($7.3M actual vs. $6.0M requirement).
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Azitra(AZTR) the EBIT is -3.419 M (-19.08%), Beat estimate;the EPS is -0.17 (+85.82%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.00B19.08%
-0.00B25.39%
+0.00B6.31%
EPSExceed expectations
-0.1785.82%
-0.22581.23%
+0.05504.59%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf